Extended-Release Naltrexone To Prevent Relapse Among Opioid Dependent, Criminal Justice System Involved Adults: Rationale and Design of a Randomized Controlled Effectiveness Trial

BACKGROUND: Extended-release naltrexone (XR-NTX, Vivitrol® Alkermes Inc.) is an injectable monthly sustained-release mu opioid receptor antagonist. XR-NTX is a potentially effective intervention for opioid use disorders and as relapse prevention among criminal justice system (CJS) populations. METHO...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Contemp Clin Trials
Main Authors: Lee, Joshua D., Friedmann, Peter D., Boney, Tamara Y., Hoskinson, Randall A., McDonald, Ryan, Gordon, Michael, Fishman, Marc, Chen, Donna T., Bonnie, Richard J., Kinlock, Timothy W., Nunes, Edward V., Cornish, James W., O’Brien, Charles P.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4380547/
https://ncbi.nlm.nih.gov/pubmed/25602580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cct.2015.01.005
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados